Clinical Trial Update: Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

View source ↗

Summary

A prospective, US-based multi-center validation study to evaluate Proclarix for prostate cancer risk assessment and detection; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sequenom, Inc. | Conditions: Prostate Cancer Detection | Status: RECRUITING